Don’t Let the Payers Enjoy All the Benefits of Data

By R. Lewis Dark | From the Volume XXXII, No. 11 – August 4, 2025 Issue

PROBABLY SINCE THE ADVENT OF M…

Read More

---

Regeneron Loses 23andMe Bid to TTAM Research Institute

By Jillia Schlingman | From the Volume XXXII, No. 9 – June 23, 2025 Issue

23andMe FOUNDER AND FORMER CEO ANNE WOJCICKI has successfully retained control over her company by selling it to her nonprofit medical research firm TTAM Research Institute for $305 million. This followed bidding between  TTAM Research Institute and Regeneron Pharmac…

Read More

---

As 23andMe Faces Bankruptcy, Home Testing Shows Warts

By Robert Michel | From the Volume XXXII, No. 7 – May 12, 2025 Issue

HIGH-STAKES DRAMA SURROUNDING 23ANDME’S BANKRUPTCY—including CEO Anne Wojcicki resigning to try to bid for the company she cofounded and state prosecutors urging caution about the data privacy of the company’s customers—brings up a fundamental question regarding d…

Read More

---

Review of Genetic Testing Companies During 2024

By Robert Michel | From the Volume XXXII, No. 1 – January 6, 2025 Issue

CEO SUMMARY: Investors in genetic testing companies are taking it on the chin these days. During 2024, a number of the nation’s largest firms providing genetic test services reported significant losses. Other genetic testing companies are dealing with class action lawsuits claiming that…

Read More

---

November 25, 2024, Intelligence: Late-Breaking Lab News

By Robert Michel | From the Volume XXXI, No. 16 – November 25, 2024 Issue

Disruption is happening in the consumer genetic testing marketplace. In recent weeks, news outlets in the United Kingdom reported that Atlas Biomed, a consumer genetic testing company founded in 2016, had simply “disappeared.” Malwarebytes said Atlas Biomed’s “London offices …

Read More

---

Managing Denials and Appeals of Clinical Lab, Path Claims

By Robert Michel | From the Volume XXXI No. 15 – November 4, 2024 Issue

CEO SUMMARY: Based on a study of denials and appeals involving about 20 million lab test claims, the team at XiFin Inc. presents here their findings. They also provide recommendations on steps labs can take to reduce denials and win a greater proportion of appeals. IN RECENT…

Read More

---

Invitae’s Troubled Journey: Rise, Fall, and Bankruptcy

By Robert Michel | From the Volume XXXI, No. 10 – July 22, 2024 Issue

ON MAY 7, THE REMNANTS OF GENETIC TESTING GIANT INVITAE (NYSE: NVTA) were scooped up by …

Read More

---

UK’s Genomics PLC and MassMutual Offer Free Genetic Testing to Members

By Robert Michel | From the Volume XXXI, No. 9 – July 1, 2024 Issue

CONSUMER-DRIVEN HEALTHCARE PAIRED WITH A FOCUS ON PRE­VENTATIVE MEDICINE has given birth…

Read More

---

April 29, 2024, Intelligence: Late-Breaking Lab News

By Robert Michel | From the Volume XXXI, No. 6 – April 29, 2024 Issue

It may be that the genetic data cat is out of the bag already. Nonetheless, lawmakers in Delaware are considering a bill that—among other things—would prevent life insurance companies from buying or using genetic testing data if it was obtained from ancestry companies and not from medical records…

Read More

---

February 26, 2024, Intelligence: Late-Breaking Lab News

By Robert Michel | From the Volume XXXI, No. 3 – February 26, 2024 Issue

Following an investment of $1.75 million, officials at University of Maine at Augusta (UMA) opened a new lab facility this month that allows it to double the number of medical laboratory technicians it can train, from eight to 10 to as many as 20. In its coverage of the new training …

Read More

---